PHARMA MAR, S.A. revenue for the last year amounted to 158.00 M EUR, the most of which — 156.84 M EUR — came from its highest performing source at the moment, Oncology, the year earlier bringing 191.18 M EUR. The greatest contribution to the revenue figure was made by Ireland — last year it brought PHARMA MAR, S.A. 75.36 M EUR, and the year before that — 86.79 M EUR.